Henry Schein, Inc. SEC filings document the formal disclosures of a Nasdaq-listed health care solutions company serving dental and medical practices and alternate care sites. The company’s 8-K filings report operating results, financial condition updates, press-release exhibits, leadership changes, board actions, and executive-compensation matters.
Proxy materials cover annual meeting matters, director and board-governance disclosures, and stockholder voting procedures. The filing record also identifies Henry Schein’s common stock, par value $0.01 per share, traded under HSIC on the Nasdaq Global Select Market, along with related corporate and Inline XBRL cover-page disclosures.
Henry Schein (HSIC) announced that Emmanuel Caprais will begin as Senior Financial Advisor on October 12, 2026, and become Senior Vice President and CFO on November 4. Ronald N. South will remain Senior Vice President and CFO and principal financial and accounting officer through November 3, including through completion of the third-quarter earnings process, then transition to Senior Advisor. Caprais’s offer provides a $750,000 annual base salary and a $750,000 target annual bonus opportunity, subject to performance criteria. He is eligible for a $25,000 cash sign-on bonus, payable within 30 days of his start date if he remains employed through payment, and a $250,000 sign-on equity award to be granted in December 2026, subject to continued employment through grant and split equally between performance- and time-based restricted stock units. A 2027 long-term incentive award is expected to have an estimated $2.5 million grant-date fair value and be granted in March 2027, subject to continued employment through grant.
Henry Schein, Inc. (HSIC) entered into a Fourth Amended and Restated Revolving Credit Agreement on September 21, 2026, amending its existing revolving credit facility. The agreement increases the aggregate revolving credit commitments from $1.0 billion to $1.25 billion and extends the termination date to September 19, 2031.
The facility may be used for working capital and general corporate purposes, including capital expenditures, repurchases of Henry Schein’s capital stock, permitted refinancing of existing debt, and funding potential acquisitions. The agreement includes customary representations, warranties, affirmative and negative covenants, and events of default, such as payment defaults, cross-defaults to other material indebtedness, bankruptcy or insolvency, defined change in control, and covenant breaches.
HENRY SCHEIN INC (HSIC) executive Andrea Albertini, CEO, Global Distribution & Technology, reported two share dispositions on September 8, 2026. Albertini surrendered 603 shares of common stock valued at $88.86 per share to Henry Schein to satisfy tax withholding tied to the vesting of a September 8, 2023 grant of performance-based restricted stock units, and separately disposed of 3,984 shares directly back to the company for no stated consideration. No transactions were reported under a Rule 10b5-1 trading plan.
Henry Schein, Inc. insider Stanley M. Bergman has filed notice of a proposed sale of 35,257 shares of Common Stock through J.P. Morgan Securities LLC on or after August 14, 2026 on NASDAQ. The filing lists an estimated aggregate market value of $3,177,361 for these shares. The shares were originally acquired via a share swap, with an acquisition date noted as September 30, 1994.
The disclosure also lists sales of Common Stock during the prior three months: the Bergman Family 2010 Trust #2, LLC sold 14,371 shares for $1,170,268 on June 16, 2026, and Stanley M. Bergman sold 2,622 shares for $213,517 on the same date.
FMR LLC and Abigail P. Johnson report beneficial ownership of common stock of Henry Schein, Inc. on a Schedule 13G. FMR LLC reports beneficial ownership of 7,553,900.88 shares of common stock, representing 6.6% of the class. FMR LLC has sole voting power over 6,786,663.10 shares and sole dispositive power over 7,553,900.88 shares, with no shared voting or dispositive power.
Abigail P. Johnson reports beneficial ownership of 7,553,900.88 shares, or 6.6% of the class, with sole dispositive power over these shares and no voting or shared powers. One or more other persons have rights to receive dividends or sale proceeds from these shares, but no such person holds more than five percent of the outstanding common stock.
Henry Schein, Inc. reported Q2 2026 net sales of $3,458 million, up from $3,240 million in Q2 2025. Net income attributable to Henry Schein was $94 million versus $86 million, with diluted EPS of $0.82 versus $0.70. Growth came across segments, led by Global Distribution and Value‑Added Services with $2,905 million in net sales.
For the first six months of 2026, net sales were $6,826 million and diluted EPS was $1.74. Operating cash flow was $145 million, while $128 million was used in investing and $48 million in financing, including $325 million of share repurchases. Total debt, including bank credit lines and long‑term borrowings, was $3,462 million at June 27, 2026. The company continued its 2024 restructuring plan, recording $41 million of restructuring and related costs year‑to‑date, and completed acquisitions with total consideration of $93 million, adding $56 million of goodwill and $35 million of identifiable intangibles.
Henry Schein, Inc. reported higher second-quarter 2026 results, with net sales of $3.458 billion, up 6.7% from the prior-year quarter, driven by 4.6% internal sales growth, contributions from acquisitions, and foreign currency tailwinds. Global Distribution and Value-Added Services sales grew 6.6%, Global Specialty Products 8.7%, and Global Technology 8.2%.
GAAP net income attributable to Henry Schein was $94 million, or $0.82 diluted EPS, versus $86 million and $0.70 a year ago. Non-GAAP net income was $145 million, or $1.27 diluted EPS, compared with $135 million and $1.10. Adjusted EBITDA reached $288 million, up from $256 million. For the first half of 2026, net sales were $6.826 billion, up 6.5%. The company raised 2026 guidance to non-GAAP diluted EPS of $5.29–$5.39, total sales growth of 4.5%–5.5%, and mid to high-single-digit Adjusted EBITDA growth, and repurchased 2.6 million shares in the quarter for $200 million.
Henry Schein, Inc. announced a leadership restructuring, creating a Henry Schein Leadership Team to replace its Executive Management Committee and integrating its global supply chain with its global distribution group. The company states these changes are intended to sharpen strategic priorities, accelerate execution, and enhance collaboration.
Effective October 30, 2026, Executive Vice Presidents Michael S. Ettinger and Mark E. Mlotek and Senior Vice President James Mullins will leave their current roles and continue as Senior Advisors, with Ettinger and Mlotek entitled to payments and benefits under the Executive Severance Plan. Henry Schein reported $13.2 billion in 2025 sales and an approximately 11.0 percent compound annual growth rate since its 1995 IPO.
HSIC filed a Form 144 disclosing a proposed resale of common stock through Fidelity Brokerage Services LLC. The filing lists 28,791 shares and a value of $2,426,793.39, with a broker address in Smithfield, RI and NASDAQ as the market. The filing itemizes multiple restricted stock vesting lots by vesting date and share count.
Company HSIC (Form 144): This filing lists proposed sales of Common Stock by affiliated holders. The excerpt identifies multiple grant/transfer dates and proposed sale activity, including entries dated 03/01/2019, 03/16/2026, and 05/21/2026. The filing names a transferee listed as Bergman Family 2010 Trust #2 LLC and notes prior issuer-originated acquisitions on 03/02/2015 and 03/02/2018.
The excerpt includes numeric entries such as 1,373,096.97 and 113,916,757, and shows an intended sale routing via J.P. Morgan Securities LLC. The filing is a notice of proposed resale by affiliates under Form 144; specific quantities per individual proposed sale are limited in the excerpt.